Arcadia Biosciences, Inc. (RKDA)
NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
As of 02:50PM EDT. Market open.
Currency in USD
Valuation Measures4
| Market Cap (intraday) | 2.79M |
| Enterprise Value | -7.84M |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 0.48 |
| Price/Book (mrq) | 0.22 |
| Enterprise Value/Revenue | -1.47 |
| Enterprise Value/EBITDA | 0.58 |
Trading Information
Stock Price History
| Beta (5Y Monthly) | 0.61 |
| 52-Week Change 3 | -64.78% |
| S&P500 52-Week Change 3 | 23.10% |
| 52 Week High 3 | 7.3000 |
| 52 Week Low 3 | 1.8510 |
| 50-Day Moving Average 3 | 2.3388 |
| 200-Day Moving Average 3 | 3.0988 |
Share Statistics
| Avg Vol (3 month) 3 | 20.78k |
| Avg Vol (10 day) 3 | 21.13k |
| Shares Outstanding 5 | 1.36M |
| Implied Shares Outstanding 6 | 1.36M |
| Float 8 | 1.14M |
| % Held by Insiders 1 | 2.49% |
| % Held by Institutions 1 | 20.53% |
| Shares Short (Apr 15, 2024) 4 | 4.08k |
| Short Ratio (Apr 15, 2024) 4 | 0.15 |
| Short % of Float (Apr 15, 2024) 4 | 0.30% |
| Short % of Shares Outstanding (Apr 15, 2024) 4 | 0.30% |
| Shares Short (prior month Mar 15, 2024) 4 | 3.65k |
Dividends & Splits
| Forward Annual Dividend Rate 4 | N/A |
| Forward Annual Dividend Yield 4 | N/A |
| Trailing Annual Dividend Rate 3 | 0.00 |
| Trailing Annual Dividend Yield 3 | 0.00% |
| 5 Year Average Dividend Yield 4 | N/A |
| Payout Ratio 4 | 0.00% |
| Dividend Date 3 | Jan 24, 2018 |
| Ex-Dividend Date 4 | N/A |
| Last Split Factor 2 | 1:40 |
| Last Split Date 3 | Mar 01, 2023 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | Dec 31, 2023 |
| Most Recent Quarter (mrq) | Dec 31, 2023 |
Profitability
| Profit Margin | -262.31% |
| Operating Margin (ttm) | -240.26% |
Management Effectiveness
| Return on Assets (ttm) | -34.50% |
| Return on Equity (ttm) | -78.36% |
Income Statement
| Revenue (ttm) | 5.33M |
| Revenue Per Share (ttm) | 4.31 |
| Quarterly Revenue Growth (yoy) | 57.30% |
| Gross Profit (ttm) | N/A |
| EBITDA | -13.13M |
| Net Income Avi to Common (ttm) | -13.16M |
| Diluted EPS (ttm) | -10.6400 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 11.64M |
| Total Cash Per Share (mrq) | 8.54 |
| Total Debt (mrq) | 1.01M |
| Total Debt/Equity (mrq) | 7.93% |
| Current Ratio (mrq) | 4.17 |
| Book Value Per Share (mrq) | 9.99 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -15.29M |
| Levered Free Cash Flow (ttm) | -5.73M |
© 2024 Yahoo. All rights reserved.